01 17GILEAD SCIENCES INC
02 5MSD MERCK CO
01 110039718*PED
02 17125879
03 17176220
04 17176220*PED
05 17635704
06 17635704*PED
07 18148374
08 18148374*PED
09 38486975
10 18633219
11 18633219*PED
12 18841310
13 18981103
14 19891239
15 110039718
16 110603282
17 110842751
18 110857102
19 18981103*PED
20 19891239*PED
01 8Y
02 14Blank
01 15Y
02 7Blank
01 12025-04-21
02 12025-12-09
03 12026-08-27
04 22026-10-26
05 12027-02-27
06 22027-04-26
07 22029-09-03
08 22030-03-03
09 12030-04-30
10 12030-10-30
11 32032-08-30
12 12032-10-06
13 12033-01-14
14 12033-04-06
15 22036-11-29
Patent Expiration Date : 2030-04-30
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8633219
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2030-04-30
Patent Expiration Date : 2026-10-26
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 7635704
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2026-10-26
Patent Expiration Date : 2025-12-09
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8841310
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-12-09
Patent Expiration Date : 2029-09-03
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8148374
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-1279
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2026-08-27
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 7176220
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2026-08-27
Patent Expiration Date : 2029-09-03
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 9891239
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 203100
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2029-09-03
Patent Expiration Date : 2025-04-21
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 7125879
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 202123
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2025-04-21
Patent Expiration Date : 2033-01-14
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 10857102
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202123
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-01-14
Patent Expiration Date : 2032-10-06
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 10039718
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 203100
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-10-06
Patent Expiration Date : 2026-10-26
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US Patent Number : 8981103
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 203100
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-10-26
